| Net Cash Provided by (Used in) Operating Activities |
-405K |
USD |
-580% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
1.37M |
USD |
+17821% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
45M |
shares |
0% |
Q3 2025 |
Q3 2025 |
| Common Stock, Shares, Issued |
11.7M |
shares |
+629% |
Q3 2025 |
Q3 2025 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q3 2025 |
Q3 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
684K |
USD |
+681% |
Q3 2025 |
Q3 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
56 |
USD |
-72.4% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
12.4M |
USD |
+0.59% |
Q3 2025 |
Q3 2025 |
| Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent |
0.21 |
pure |
|
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
9.04M |
USD |
+2.88% |
Q4 2024 |
FY 2024 |
| Preferred Stock, Shares Issued |
39.8K |
shares |
|
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Authorized |
900K |
shares |
|
Q3 2025 |
Q3 2025 |
| Additional Paid in Capital |
40.6M |
USD |
+15.2% |
Q3 2025 |
Q3 2025 |
| Preferred Stock, Shares Outstanding |
39.8K |
shares |
|
Q3 2025 |
Q3 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
164K |
USD |
|
Q3 2024 |
Q3 2024 |
| Share-based Payment Arrangement, Expense |
361K |
USD |
|
Q4 2023 |
FY 2024 |
| Interest Expense |
5.46K |
USD |
|
Q2 2023 |
Q2 2023 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
|
Q3 2025 |
Q3 2025 |